Nagayama, D., Saiki, A., & Shirai, K. (2021). The Anti-Cancer Effect of Pitavastatin May Be a Drug-Specific Effect: Subgroup Analysis of the TOHO-LIP Study. Vascular Health & Risk Management, 17, 169-174.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Nagayama, Daiji, Atsuhito Saiki, y Kohji Shirai. "The Anti-Cancer Effect of Pitavastatin May Be a Drug-Specific Effect: Subgroup Analysis of the TOHO-LIP Study."
Vascular Health & Risk Management 17 (2021): 169-174.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Nagayama, Daiji, et al. "The Anti-Cancer Effect of Pitavastatin May Be a Drug-Specific Effect: Subgroup Analysis of the TOHO-LIP Study."
Vascular Health & Risk Management, vol. 17, 2021, pp. 169-174.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.